Global Logistics Management 2
Introduction
Abbott Laboratories has invented a medical device to test coronavirus. This device can tell if
a person is infected within five minutes. The medical device is quite small and can be used in
any health care organization. The medical device is capable of doing 50,000 tests in a day.
This device has been accessible from April 1. The molecular tests to be conducted by the
device look for fragments of the coronavirus genome which can be easily detected and
accessible at the high levels. Complete research rules out to infection and takes thirteen
minutes. Abbott has attained emergency use approval from the U.S. Food and Drug
Administration for the use of approved laboratories and patient care systems. The U.S has
already struggled to detect the virus through various tests. The medical device invented by
Abbott Laboratories can offer an incredible prospect for front-line caregivers. The clinics will
be able to conduct a test within a short period.
How product can be distributed in the United States?
U.S. labs are facing problems even after the improvement in the testing. The manufacturing
of new kits has been increased but the channel is overwhelmed by new hurdles. The supplies
are running short and labs do not have enough capacity to do testing. On the initial basis, the
labs had to send tests to the commercial labs which took 12 days to process. In such a
situation, it has become quite important for the U.S to go for medical devices which can
results in the tests within the shortest period. Abbott is seriously going to provide a
tremendous opportunity to the front-line caregivers in the U.S to diagnose infections and
close the gap with the testing. The clinic will be capable of resulting quickly with the help of
the devices (Li & Wang, 2018). The technology will construct on Illinois-based Abbott’s ID
now platform.
There is no restriction on essential services such as medicines and equipment. Although,
there is a restriction on some of the services while lockdown but medical-related products and
services are not one of them. Abbott will distribute medical devices in the U.S. the devices
will be distributed in labs and health care organizations as per the number of cases identified
(Erdogan & Kavas, 2020). A free passage can be provided to people involved in the
manufacturing of medical products and services so that they can reach to clinics and
hospitals. The administration can be urged for the assistance and offer a free passage to
people in the supply chain of essential commodities to reach factories, manufacturing plants
and thereafter to reach hospitals and clinics (Lin & Chang, 2018). The public transport for

+13062052269

info@desklib.com

Global Logistics Management Assignment

Contribute Materials

Related Documents